ACB
Price
$4.54
Change
+$0.07 (+1.57%)
Updated
Jul 3 closing price
Capitalization
238.86M
32 days until earnings call
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.44B
Interact to see
Advertisement

ACB vs TSMRF

Header iconACB vs TSMRF Comparison
Open Charts ACB vs TSMRFBanner chart's image
Aurora Cannabis
Price$4.54
Change+$0.07 (+1.57%)
Volume$708.07K
Capitalization238.86M
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.44B
ACB vs TSMRF Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. TSMRF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and TSMRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ACB: $4.54 vs. TSMRF: $23.74)
Brand notoriety: ACB: Notable vs. TSMRF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 58% vs. TSMRF: 100%
Market capitalization -- ACB: $238.86M vs. TSMRF: $1.44B
ACB [@Pharmaceuticals: Other] is valued at $238.86M. TSMRF’s [@Pharmaceuticals: Other] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, TSMRF is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 5 TA indicator(s) are bullish.

  • ACB’s TA Score: 5 bullish, 5 bearish.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +6.57% price change this week, while TSMRF (@Pharmaceuticals: Other) price change was -15.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

ACB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSMRF($1.44B) has a higher market cap than ACB($239M). ACB YTD gains are higher at: 6.824 vs. TSMRF (-15.672). TSMRF has higher annual earnings (EBITDA): 37B vs. ACB (-1.64B). TSMRF has more cash in the bank: 93.7B vs. ACB (149M). ACB has less debt than TSMRF: ACB (103M) vs TSMRF (79.7B). TSMRF has higher revenues than ACB: TSMRF (138B) vs ACB (212M).
ACBTSMRFACB / TSMRF
Capitalization239M1.44B17%
EBITDA-1.64B37B-4%
Gain YTD6.824-15.672-44%
P/E RatioN/A12.64-
Revenue212M138B0%
Total Cash149M93.7B0%
Total Debt103M79.7B0%
FUNDAMENTALS RATINGS
ACB vs TSMRF: Fundamental Ratings
ACB
TSMRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8920
PRICE GROWTH RATING
1..100
6284
P/E GROWTH RATING
1..100
8497
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSMRF's Valuation (11) in the null industry is somewhat better than the same rating for ACB (55) in the Pharmaceuticals Other industry. This means that TSMRF’s stock grew somewhat faster than ACB’s over the last 12 months.

TSMRF's Profit vs Risk Rating (100) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that TSMRF’s stock grew similarly to ACB’s over the last 12 months.

TSMRF's SMR Rating (20) in the null industry is significantly better than the same rating for ACB (89) in the Pharmaceuticals Other industry. This means that TSMRF’s stock grew significantly faster than ACB’s over the last 12 months.

ACB's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as TSMRF (84) in the null industry. This means that ACB’s stock grew similarly to TSMRF’s over the last 12 months.

ACB's P/E Growth Rating (84) in the Pharmaceuticals Other industry is in the same range as TSMRF (97) in the null industry. This means that ACB’s stock grew similarly to TSMRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBTSMRF
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
9%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNCTF15.60N/A
N/A
Orange
GUROF1.32N/A
N/A
Guru Organic Energy Co.
BPTSY1.45N/A
N/A
Biophytis SA
CADNF6.74N/A
N/A
Cascades Inc.
CBUMF0.55N/A
N/A
China National Buildings Material

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with CGC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+1.57%
CGC - ACB
63%
Loosely correlated
+7.56%
OGI - ACB
60%
Loosely correlated
+3.62%
CRON - ACB
56%
Loosely correlated
+2.00%
TLRY - ACB
55%
Loosely correlated
+11.03%
CRDL - ACB
35%
Loosely correlated
+10.79%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
ACB - TSMRF
30%
Poorly correlated
+1.57%
HNSPF - TSMRF
29%
Poorly correlated
N/A
GEDSF - TSMRF
22%
Poorly correlated
N/A
TLRY - TSMRF
22%
Poorly correlated
+11.03%
CGC - TSMRF
21%
Poorly correlated
+7.56%
More